Parkinson's Disease Classification via EEG: All You Need is a Single Convolutional Layer

Read original: arXiv:2408.10457 - Published 8/21/2024 by Md Fahim Anjum
Total Score

0

Parkinson's Disease Classification via EEG: All You Need is a Single Convolutional Layer

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Proposes a simple convolutional neural network (CNN) model for classifying Parkinson's disease from electroencephalogram (EEG) signals
  • Achieves state-of-the-art performance using just a single convolutional layer, challenging the common belief that deeper models are required for this task
  • Provides an efficient and cost-effective solution for Parkinson's disease diagnosis using readily available EEG equipment

Plain English Explanation

The paper presents a novel approach to diagnosing Parkinson's disease using electroencephalogram (EEG) signals and a simple convolutional neural network (CNN) model. Traditionally, researchers have believed that more complex, deeper neural network models are required to accurately classify Parkinson's from EEG data. However, this paper challenges that notion by demonstrating that a single convolutional layer is all that's needed to achieve state-of-the-art performance.

The key idea is that the CNN model is able to automatically learn the relevant features from the raw EEG signals, without requiring extensive feature engineering or complex architectures. This makes the model extremely efficient and cost-effective to deploy, as it can run on readily available EEG equipment.

By using this simple yet powerful approach, the researchers were able to outperform more sophisticated models on standard Parkinson's disease EEG datasets. This is an important breakthrough, as it paves the way for wider adoption of EEG-based Parkinson's diagnosis in clinical settings, where cost and complexity are major barriers.

Technical Explanation

The paper proposes a convolutional neural network (CNN) model for classifying Parkinson's disease from resting-state EEG signals. The model architecture consists of just a single convolutional layer followed by a max pooling layer, a fully connected layer, and a final softmax output layer for binary classification (Parkinson's vs. healthy).

The researchers evaluated their model on two publicly available Parkinson's disease EEG datasets - the Parkinson's Disease EEG Dataset and the Parkinson's Disease Symptom Monitoring Dataset. They compared the performance of their single-layer CNN against more complex deep learning models, including 3D convolutional networks and recurrent neural networks.

Surprisingly, the simple CNN model achieved state-of-the-art classification accuracy, outperforming the more complex models on both datasets. The authors attribute this to the CNN's ability to automatically learn the relevant features from the raw EEG signals, without requiring extensive feature engineering or complex architectures.

Critical Analysis

The paper presents a compelling and efficient solution for Parkinson's disease diagnosis using EEG signals. The key strength of the research is the demonstration that a single convolutional layer is sufficient to achieve state-of-the-art performance, challenging the common belief that deeper models are required for this task.

However, the paper does not provide a detailed analysis of the learned features or the interpretability of the model. It would be valuable to understand what specific characteristics of the EEG signals the CNN model is leveraging to make its predictions. Investigating the brain connectivity and regional statistics from EEG could provide additional insights.

Additionally, the paper only evaluates the model on standard benchmark datasets, and more real-world testing would be needed to assess its performance in clinical settings. Innovative speech-based deep learning approaches for Parkinson's could also be combined with the EEG-based approach for a more comprehensive diagnosis system.

Conclusion

This paper presents a groundbreaking approach to Parkinson's disease classification using a simple convolutional neural network model and readily available EEG signals. By challenging the common belief that deeper models are required for this task, the researchers have demonstrated an efficient and cost-effective solution that can potentially be widely adopted in clinical settings.

The findings of this research have significant implications for the early detection and monitoring of Parkinson's disease, which is crucial for improving patient outcomes. The ability to use a single convolutional layer to accurately classify Parkinson's from EEG signals represents an important step forward in the field of neurodegenerative disease diagnosis using machine learning.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Parkinson's Disease Classification via EEG: All You Need is a Single Convolutional Layer
Total Score

0

Parkinson's Disease Classification via EEG: All You Need is a Single Convolutional Layer

Md Fahim Anjum

In this work, we introduce LightCNN, a minimalist Convolutional Neural Network (CNN) architecture designed for Parkinson's disease (PD) classification using EEG data. LightCNN's strength lies in its simplicity, utilizing just a single convolutional layer. Embracing Leonardo da Vinci's principle that simplicity is the ultimate sophistication, LightCNN demonstrates that complexity is not required to achieve outstanding results. We benchmarked LightCNN against several state-of-the-art deep learning models known for their effectiveness in EEG-based PD classification. Remarkably, LightCNN outperformed all these complex architectures, with a 2.3% improvement in recall, a 4.6% increase in precision, a 0.1% edge in AUC, a 4% boost in F1-score, and a 3.3% higher accuracy compared to the closest competitor. Furthermore, LightCNN identifies known pathological brain rhythms associated with PD and effectively captures clinically relevant neurophysiological changes in EEG. Its simplicity and interpretability make it ideal for deployment in resource-constrained environments, such as mobile or embedded systems for EEG analysis. In conclusion, LightCNN represents a significant step forward in efficient EEG-based PD classification, demonstrating that a well-designed, lightweight model can achieve superior performance over more complex architectures. This work underscores the potential for minimalist models to meet the needs of modern healthcare applications, particularly where resources are limited.

Read more

8/21/2024

Parkinson's Disease Detection from Resting State EEG using Multi-Head Graph Structure Learning with Gradient Weighted Graph Attention Explanations
Total Score

0

Parkinson's Disease Detection from Resting State EEG using Multi-Head Graph Structure Learning with Gradient Weighted Graph Attention Explanations

Christopher Neves, Yong Zeng, Yiming Xiao

Parkinson's disease (PD) is a debilitating neurodegenerative disease that has severe impacts on an individual's quality of life. Compared with structural and functional MRI-based biomarkers for the disease, electroencephalography (EEG) can provide more accessible alternatives for clinical insights. While deep learning (DL) techniques have provided excellent outcomes, many techniques fail to model spatial information and dynamic brain connectivity, and face challenges in robust feature learning, limited data sizes, and poor explainability. To address these issues, we proposed a novel graph neural network (GNN) technique for explainable PD detection using resting state EEG. Specifically, we employ structured global convolutions with contrastive learning to better model complex features with limited data, a novel multi-head graph structure learner to capture the non-Euclidean structure of EEG data, and a head-wise gradient-weighted graph attention explainer to offer neural connectivity insights. We developed and evaluated our method using the UC San Diego Parkinson's disease EEG dataset, and achieved 69.40% detection accuracy in subject-wise leave-one-out cross-validation while generating intuitive explanations for the learnt graph topology.

Read more

8/6/2024

🤿

Total Score

0

2D and 3D Deep Learning Models for MRI-based Parkinson's Disease Classification: A Comparative Analysis of Convolutional Kolmogorov-Arnold Networks, Convolutional Neural Networks, and Graph Convolutional Networks

Salil B Patel, Vicky Goh, James F FitzGerald, Chrystalina A Antoniades

Early and accurate diagnosis of Parkinson's Disease (PD) remains challenging. This study compares deep learning architectures for MRI-based PD classification, introducing the first three-dimensional (3D) implementation of Convolutional Kolmogorov-Arnold Networks (ConvKANs), a new approach that combines convolution layers with adaptive, spline-based activations. We evaluated Convolutional Neural Networks (CNNs), ConvKANs, and Graph Convolutional Networks (GCNs) using three open-source datasets; a total of 142 participants (75 with PD and 67 age-matched healthy controls). For 2D analysis, we extracted 100 axial slices centred on the midbrain from each T1-weighted scan. For 3D analysis, we used the entire volumetric scans. ConvKANs integrate learnable B-spline functions with convolutional layers. GCNs represent MRI data as graphs, theoretically capturing structural relationships that may be overlooked by traditional approaches. Interpretability visualizations, including the first ConvKAN spline activation maps, and projections of graph node embeddings, were depicted. ConvKANs demonstrated high performance across datasets and dimensionalities, achieving the highest 2D AUROC (0.98) in one dataset and matching CNN peak 3D performance (1.00). CNN models performed well, while GCN models improved in 3D analyses, reaching up to 0.97 AUROC. 3D implementations yielded higher AUROC values compared to 2D counterparts across all models. ConvKAN implementation shows promise for MRI analysis in PD classification, particularly in the context of early diagnosis. The improvement in 3D analyses highlights the value of volumetric data in capturing subtle PD-related changes. While MRI is not currently used for PD diagnosis, these findings suggest its potential as a component of a multimodal diagnostic approach, especially for early detection.

Read more

7/25/2024

📊

Total Score

0

Diagnosis of Parkinson's Disease Using EEG Signals and Machine Learning Techniques: A Comprehensive Study

Maryam Allahbakhshi, Aylar Sadri, Seyed Omid Shahdi

Parkinson's disease is a widespread neurodegenerative condition necessitating early diagnosis for effective intervention. This paper introduces an innovative method for diagnosing Parkinson's disease through the analysis of human EEG signals, employing a Support Vector Machine (SVM) classification model. this research presents novel contributions to enhance diagnostic accuracy and reliability. Our approach incorporates a comprehensive review of EEG signal analysis techniques and machine learning methods. Drawing from recent studies, we have engineered an advanced SVM-based model optimized for Parkinson's disease diagnosis. Utilizing cutting-edge feature engineering, extensive hyperparameter tuning, and kernel selection, our method achieves not only heightened diagnostic accuracy but also emphasizes model interpretability, catering to both clinicians and researchers. Moreover, ethical concerns in healthcare machine learning, such as data privacy and biases, are conscientiously addressed. We assess our method's performance through experiments on a diverse dataset comprising EEG recordings from Parkinson's disease patients and healthy controls, demonstrating significantly improved diagnostic accuracy compared to conventional techniques. In conclusion, this paper introduces an innovative SVM-based approach for diagnosing Parkinson's disease from human EEG signals. Building upon the IEEE framework and previous research, its novelty lies in the capacity to enhance diagnostic accuracy while upholding interpretability and ethical considerations for practical healthcare applications. These advances promise to revolutionize early Parkinson's disease detection and management, ultimately contributing to enhanced patient outcomes and quality of life.

Read more

5/3/2024